Found 250 matching trials
Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus
N/AThis study is conducted in Europe. The aim of this non-interventional study...
Location
Novo Nordisk Investigational Site
IDegLira HIGH Trial
PHASE3Basal-bolus insulin therapy is recommended for patients with poorly control...
Location
Grady Health System
A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes
PHASE1This trial was conducted in Europe. The aim of this study was to investigat...
Location
Novo Nordisk Investigational Site
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
PHASE3This trial is conducted in the United States of America (USA). The aim of t...
Location
Novo Nordisk Investigational Site
Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin
EARLY_PHASE1This is a pilot study to examine and compare the efficacy of supervised inj...
GLP-1 REceptor Agonists and Real World EvIdeNce
N/AGlucagon-like peptide-1 receptor agonists (GLP-1RA) are powerful second-lin...
Location
Servizio di Diabetologia UOC Medicina Generale
Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes
PHASE1This trial is conducted in Europe. The aim of this trial is to investigate ...
Location
Multiple Locations
Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin Degludec
N/ARetrospective multicenter study analyzing data gathered from medical record...
Location
Universitaire Ziekenhuizen Leuven
Investigation of the Response Relationship of NN5401 in Type 1 Diabetics
PHASE1This trial was conducted in Europe. The aim of this clinical trial was to e...
Location
Novo Nordisk Investigational Site
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
PHASE4BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Location
Unit of Endocrinology and Metabolic Diseases